Geode Capital Management’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6K | Hold |
|
|||||
|
2025
Q1 | $17.6K | Buy |
|
|||||
|
2024
Q4 | $12.4K | Buy |
|
|||||
|
2024
Q3 | $5.53K | Sell |
|
|||||
|
2024
Q2 | $20.3K | Buy |
|
|||||
|
2024
Q1 | $48.3K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $12.3K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $9K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $18K | Hold |
|
|||||
|
2022
Q1 | $96K | Buy |
|
|||||
|
2021
Q4 | $116K | Buy |
|
|||||
|
2021
Q3 | $134K | Buy |
|
|||||
|
2021
Q2 | $355K | Buy |
|
|||||
|
2021
Q1 | $343K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Hold |
|